Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Esperion Therapeutics, Inc. | 679,348 | reported | 17 Mar 2026 | tx 20+1,575,720−36,792 |
| Trillium Therapeutics Inc. | 0 | reported | 17 Nov 2021 | tx 2+190,000−190,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 17 Mar 2026 | SALE | Esperion Therapeutics, Inc. | 5,708 | 2.70 USD | |
| 13 Mar 2026 | GRANT_AWARD | Esperion Therapeutics, Inc. | 300,840 | 0.00 USD | |
| 13 Mar 2026 | GRANT_AWARD | Esperion Therapeutics, Inc. | 269,230 | 0.00 USD | deriv |
| 20 Jan 2026 | SALE | Esperion Therapeutics, Inc. | 1,689 | 2.88 USD | |
| 17 Dec 2025 | SALE | Esperion Therapeutics, Inc. | 6,517 | 3.67 USD | |
| 17 Oct 2025 | SALE | Esperion Therapeutics, Inc. | 1,248 | 2.62 USD | |
| 17 Sept 2025 | SALE | Esperion Therapeutics, Inc. | 6,267 | 2.80 USD | |
| 17 Jul 2025 | SALE | Esperion Therapeutics, Inc. | 1,304 | 1.13 USD | |
| 17 Jun 2025 | SALE | Esperion Therapeutics, Inc. | 6,422 | 1.15 USD | |
| 14 Mar 2025 | GRANT_AWARD | Esperion Therapeutics, Inc. | 224,000 | 0.00 USD | |
| 14 Mar 2025 | GRANT_AWARD | Esperion Therapeutics, Inc. | 201,000 | 0.00 USD | deriv |
| 14 Mar 2024 | GRANT_AWARD | Esperion Therapeutics, Inc. | 100,000 | 0.00 USD | |
| 14 Mar 2024 | GRANT_AWARD | Esperion Therapeutics, Inc. | 150,000 | 0.00 USD | deriv |
| 19 Apr 2023 | SALE | Esperion Therapeutics, Inc. | 1,290 | 1.27 USD | |
| 14 Mar 2023 | GRANT_AWARD | Esperion Therapeutics, Inc. | 20,500 | 0.00 USD | |
| 14 Mar 2023 | GRANT_AWARD | Esperion Therapeutics, Inc. | 86,900 | 0.00 USD | deriv |
| 18 Jan 2023 | SALE | Esperion Therapeutics, Inc. | 6,347 | 7.00 USD | |
| 07 Jun 2022 | GRANT_AWARD | Esperion Therapeutics, Inc. | 52,000 | 0.00 USD | deriv |
| 27 Jan 2022 | GRANT_AWARD | Esperion Therapeutics, Inc. | 70,800 | 0.00 USD | |
| 27 Jan 2022 | GRANT_AWARD | Esperion Therapeutics, Inc. | 100,450 | 0.00 USD | deriv |
| 17 Nov 2021 | OTHER | Trillium Therapeutics Inc. | 190,000 | 0.00 USD | deriv |
| 03 May 2021 | GRANT_AWARD | Trillium Therapeutics Inc. | 190,000 | 0.00 USD | deriv |